Which statement is true regarding pharmacotherapy in BMI management?

Which statement is true regarding pharmacotherapy in BMI management?

• A. Pharmacotherapy is never used.
• B. Pharmacotherapy is always required for BMI 25.
• C. Pharmacotherapy is included in BMI 30 with or without comorbidity.
• D. Pharmacotherapy is only used after bariatric surgery.

Answer: (C)

Pharmacotherapy can be a helpful part of obesity treatment when lifestyle changes alone aren’t enough. It is appropriate to consider weight‑loss medications for people with a BMI of 30 or higher, and also for those with a BMI of 27 or higher if they have weight‑related health problems. Because of that, including pharmacotherapy in the plan at BMI 30 is correct, whether or not there are comorbidities. This reflects a multi‑pronged approach to achieve meaningful weight loss. The other statements imply extremes (never, always at BMI 25, or only after surgery) that don’t match standard practice.

Pharmacotherapy can be a helpful part of obesity treatment when lifestyle changes alone aren’t enough. It is appropriate to consider weight‑loss medications for people with a BMI of 30 or higher, and also for those with a BMI of 27 or higher if they have weight‑related health problems. Because of that, including pharmacotherapy in the plan at BMI 30 is correct, whether or not there are comorbidities. This reflects a multi‑pronged approach to achieve meaningful weight loss. The other statements imply extremes (never, always at BMI 25, or only after surgery) that don’t match standard practice.